Cipla
Indian multinational pharmaceutical company
Cipla ▸ Facts ▸ Comments ▸ News ▸ Videos
Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai. Cipla primarily develops medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and other medical conditions.
0 shares | ShareTweetSavePostSend |
You Might Like
Cipla JV with Manipal subsidiary and Kemwell Biopharma to develop cell therapyIndiaTimes - Published | |
Cipla launches real-time Covid-19 RT-PCR test kit, know detailsThe kit is validated by the Indian Council of Medical Research (ICMR) and is much more advanced than other RT PCR tests.DNA - Published | |
In a first, 5 Indian pharma majors ally for Covid drug trialsIn a first, five Indian pharma majors have joined hands to conduct phase-III clinical trials of investigational anti-viral drug Molnupiravir on mild Covid-19 patients. The companies include Dr Reddy's..IndiaTimes - Published | |
DCGI gives emergency use nod to Moderna’s vaccineIndian pharma major Cipla will “facilitate” the import of Covid vaccines donated by US biotech major Moderna, possibly in the near future, under licence for restricted use by India’s drug..IndiaTimes - Published | |
Cipla gets DCGI nod to import Moderna's COVID-19 vaccineIn a boost to India's fight against coronavirus, the Drug Controller General of India (DCGI) has approved the emergency use of Moderna Covid-19 vaccine in India.DNA - Published | |
Cipla gets DCGI nod to import Moderna's Covid vaccine for restricted emergency use in India: SourcesIndia's drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's Covid-19 vaccine for restricted emergency use in the country, official sources said..IndiaTimes - Published | |
COVID-19: Big relief for foreign vaccine makers as DCGI exempts post-approval bridging trialsCipla, which has been looking to commit USD 1 billion into bringing Moderna's single-dose mRNA booster vaccine to India, also requested an exemption.DNA - Published | |
Moderna's single-dose Covid-19 vaccine in India likely next year; Pfizer ready with 5 crore doses for 2021Moderna is expecting to launch a single-dose Covid-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while another US giant Pfizer is ready to offer 5 crore shots in..IndiaTimes - Published | |
Cipla introduces RT-PCR test kit 'ViraGen' in Indian market: All you need to knowViraGen is Cipla's third offering in the Covid-19 testing segment. Cipla already has partnerships for antibody detection kit and antigen test kits.DNA - Published | |
Roche, Cipla launch antibody cocktail Casirivimab and Imdevimab in India: Know price, function, benefitsThe antibody cocktail is targeted at mild-to-moderate coronavirus patients above 12 years of age or older and at least weighing 40 kg.DNA - Published | |
Companies set to double Remdesivir outputEven as the Centre announced a slew of measures to improve access of Covid-19 therapy, Remdesivir, major players including Zydus Cadila, Cipla, Mylan and Dr Reddy’s are ramping up production, which..IndiaTimes - Published |